nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosentan—ABCB11—Phenobarbital—epilepsy syndrome	0.107	0.19	CbGbCtD
Bosentan—CYP2C9—Trimethadione—epilepsy syndrome	0.035	0.0623	CbGbCtD
Bosentan—CYP2C9—Fosphenytoin—epilepsy syndrome	0.033	0.0586	CbGbCtD
Bosentan—CYP2C9—Carbamazepine—epilepsy syndrome	0.0237	0.0421	CbGbCtD
Bosentan—CYP2C9—Primidone—epilepsy syndrome	0.0221	0.0393	CbGbCtD
Bosentan—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0219	0.039	CbGbCtD
Bosentan—CYP2C9—Phenytoin—epilepsy syndrome	0.0212	0.0377	CbGbCtD
Bosentan—CYP3A4—Felbamate—epilepsy syndrome	0.0204	0.0362	CbGbCtD
Bosentan—CYP3A4—Trimethadione—epilepsy syndrome	0.0204	0.0362	CbGbCtD
Bosentan—CYP2C9—Propofol—epilepsy syndrome	0.0198	0.0352	CbGbCtD
Bosentan—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0192	0.0341	CbGbCtD
Bosentan—CYP2C9—Phenobarbital—epilepsy syndrome	0.0189	0.0336	CbGbCtD
Bosentan—CYP2C9—Diazepam—epilepsy syndrome	0.0179	0.0319	CbGbCtD
Bosentan—CYP3A4—Clonazepam—epilepsy syndrome	0.0173	0.0308	CbGbCtD
Bosentan—CYP3A4—Clobazam—epilepsy syndrome	0.0166	0.0295	CbGbCtD
Bosentan—CYP2C9—Valproic Acid—epilepsy syndrome	0.0141	0.0251	CbGbCtD
Bosentan—CYP3A4—Rufinamide—epilepsy syndrome	0.0141	0.0251	CbGbCtD
Bosentan—CYP3A4—Carbamazepine—epilepsy syndrome	0.0138	0.0245	CbGbCtD
Bosentan—CYP3A4—Primidone—epilepsy syndrome	0.0129	0.0228	CbGbCtD
Bosentan—CYP3A4—Phenytoin—epilepsy syndrome	0.0123	0.0219	CbGbCtD
Bosentan—CYP3A4—Propofol—epilepsy syndrome	0.0115	0.0205	CbGbCtD
Bosentan—CYP3A4—Phenobarbital—epilepsy syndrome	0.011	0.0196	CbGbCtD
Bosentan—CYP3A4—Acetazolamide—epilepsy syndrome	0.011	0.0196	CbGbCtD
Bosentan—CYP3A4—Midazolam—epilepsy syndrome	0.0109	0.0193	CbGbCtD
Bosentan—CYP3A4—Diazepam—epilepsy syndrome	0.0104	0.0185	CbGbCtD
Bosentan—CYP3A4—Zonisamide—epilepsy syndrome	0.0102	0.0181	CbGbCtD
Bosentan—CYP3A4—Valproic Acid—epilepsy syndrome	0.00822	0.0146	CbGbCtD
Bosentan—CYP3A4—Topiramate—epilepsy syndrome	0.00742	0.0132	CbGbCtD
Bosentan—Rash—Vigabatrin—epilepsy syndrome	6.44e-05	0.000222	CcSEcCtD
Bosentan—Dizziness—Felbamate—epilepsy syndrome	6.43e-05	0.000222	CcSEcCtD
Bosentan—Dermatitis—Vigabatrin—epilepsy syndrome	6.43e-05	0.000222	CcSEcCtD
Bosentan—Urethral disorder—Topiramate—epilepsy syndrome	6.43e-05	0.000222	CcSEcCtD
Bosentan—Pruritus—Oxcarbazepine—epilepsy syndrome	6.41e-05	0.000222	CcSEcCtD
Bosentan—Hypersensitivity—Carbamazepine—epilepsy syndrome	6.41e-05	0.000222	CcSEcCtD
Bosentan—Vision blurred—Gabapentin—epilepsy syndrome	6.4e-05	0.000221	CcSEcCtD
Bosentan—Headache—Vigabatrin—epilepsy syndrome	6.39e-05	0.000221	CcSEcCtD
Bosentan—Vomiting—Diazepam—epilepsy syndrome	6.39e-05	0.000221	CcSEcCtD
Bosentan—Anorexia—Valproic Acid—epilepsy syndrome	6.37e-05	0.00022	CcSEcCtD
Bosentan—Tremor—Gabapentin—epilepsy syndrome	6.36e-05	0.00022	CcSEcCtD
Bosentan—Rash—Diazepam—epilepsy syndrome	6.34e-05	0.000219	CcSEcCtD
Bosentan—Dermatitis—Diazepam—epilepsy syndrome	6.33e-05	0.000219	CcSEcCtD
Bosentan—Arthralgia—Pregabalin—epilepsy syndrome	6.3e-05	0.000218	CcSEcCtD
Bosentan—Chest pain—Pregabalin—epilepsy syndrome	6.3e-05	0.000218	CcSEcCtD
Bosentan—Dizziness—Zonisamide—epilepsy syndrome	6.3e-05	0.000218	CcSEcCtD
Bosentan—Headache—Diazepam—epilepsy syndrome	6.3e-05	0.000218	CcSEcCtD
Bosentan—Anxiety—Pregabalin—epilepsy syndrome	6.28e-05	0.000217	CcSEcCtD
Bosentan—Diarrhoea—Clonazepam—epilepsy syndrome	6.28e-05	0.000217	CcSEcCtD
Bosentan—Anaemia—Gabapentin—epilepsy syndrome	6.27e-05	0.000217	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	6.26e-05	0.000216	CcSEcCtD
Bosentan—Hypotension—Valproic Acid—epilepsy syndrome	6.24e-05	0.000216	CcSEcCtD
Bosentan—Asthenia—Carbamazepine—epilepsy syndrome	6.24e-05	0.000216	CcSEcCtD
Bosentan—Diarrhoea—Phenytoin—epilepsy syndrome	6.24e-05	0.000216	CcSEcCtD
Bosentan—Discomfort—Pregabalin—epilepsy syndrome	6.23e-05	0.000215	CcSEcCtD
Bosentan—Nausea—Fosphenytoin—epilepsy syndrome	6.22e-05	0.000215	CcSEcCtD
Bosentan—Diarrhoea—Oxcarbazepine—epilepsy syndrome	6.2e-05	0.000214	CcSEcCtD
Bosentan—Erythema multiforme—Topiramate—epilepsy syndrome	6.2e-05	0.000214	CcSEcCtD
Bosentan—Angioedema—Gabapentin—epilepsy syndrome	6.2e-05	0.000214	CcSEcCtD
Bosentan—Hypersensitivity—Lamotrigine—epilepsy syndrome	6.19e-05	0.000214	CcSEcCtD
Bosentan—Vomiting—Felbamate—epilepsy syndrome	6.18e-05	0.000214	CcSEcCtD
Bosentan—Dry mouth—Pregabalin—epilepsy syndrome	6.16e-05	0.000213	CcSEcCtD
Bosentan—Pruritus—Carbamazepine—epilepsy syndrome	6.16e-05	0.000213	CcSEcCtD
Bosentan—Rash—Felbamate—epilepsy syndrome	6.13e-05	0.000212	CcSEcCtD
Bosentan—Eye disorder—Topiramate—epilepsy syndrome	6.13e-05	0.000212	CcSEcCtD
Bosentan—Dermatitis—Felbamate—epilepsy syndrome	6.13e-05	0.000212	CcSEcCtD
Bosentan—Tinnitus—Topiramate—epilepsy syndrome	6.12e-05	0.000211	CcSEcCtD
Bosentan—Vertigo—Gabapentin—epilepsy syndrome	6.1e-05	0.000211	CcSEcCtD
Bosentan—Headache—Felbamate—epilepsy syndrome	6.09e-05	0.000211	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	6.09e-05	0.00021	CcSEcCtD
Bosentan—Flushing—Topiramate—epilepsy syndrome	6.09e-05	0.00021	CcSEcCtD
Bosentan—Cardiac disorder—Topiramate—epilepsy syndrome	6.09e-05	0.00021	CcSEcCtD
Bosentan—Syncope—Gabapentin—epilepsy syndrome	6.09e-05	0.00021	CcSEcCtD
Bosentan—Leukopenia—Gabapentin—epilepsy syndrome	6.07e-05	0.00021	CcSEcCtD
Bosentan—Dizziness—Clonazepam—epilepsy syndrome	6.07e-05	0.00021	CcSEcCtD
Bosentan—Nausea—Vigabatrin—epilepsy syndrome	6.06e-05	0.00021	CcSEcCtD
Bosentan—Vomiting—Zonisamide—epilepsy syndrome	6.05e-05	0.000209	CcSEcCtD
Bosentan—Insomnia—Valproic Acid—epilepsy syndrome	6.04e-05	0.000209	CcSEcCtD
Bosentan—Oedema—Pregabalin—epilepsy syndrome	6.04e-05	0.000209	CcSEcCtD
Bosentan—Anaphylactic shock—Pregabalin—epilepsy syndrome	6.04e-05	0.000209	CcSEcCtD
Bosentan—Asthenia—Lamotrigine—epilepsy syndrome	6.03e-05	0.000208	CcSEcCtD
Bosentan—Dizziness—Phenytoin—epilepsy syndrome	6.03e-05	0.000208	CcSEcCtD
Bosentan—Rash—Zonisamide—epilepsy syndrome	6e-05	0.000207	CcSEcCtD
Bosentan—Infection—Pregabalin—epilepsy syndrome	6e-05	0.000207	CcSEcCtD
Bosentan—Paraesthesia—Valproic Acid—epilepsy syndrome	6e-05	0.000207	CcSEcCtD
Bosentan—Palpitations—Gabapentin—epilepsy syndrome	6e-05	0.000207	CcSEcCtD
Bosentan—Dermatitis—Zonisamide—epilepsy syndrome	6e-05	0.000207	CcSEcCtD
Bosentan—Dizziness—Oxcarbazepine—epilepsy syndrome	6e-05	0.000207	CcSEcCtD
Bosentan—Nausea—Diazepam—epilepsy syndrome	5.97e-05	0.000206	CcSEcCtD
Bosentan—Loss of consciousness—Gabapentin—epilepsy syndrome	5.96e-05	0.000206	CcSEcCtD
Bosentan—Headache—Zonisamide—epilepsy syndrome	5.96e-05	0.000206	CcSEcCtD
Bosentan—Dyspnoea—Valproic Acid—epilepsy syndrome	5.96e-05	0.000206	CcSEcCtD
Bosentan—Diarrhoea—Carbamazepine—epilepsy syndrome	5.95e-05	0.000206	CcSEcCtD
Bosentan—Angiopathy—Topiramate—epilepsy syndrome	5.95e-05	0.000206	CcSEcCtD
Bosentan—Pruritus—Lamotrigine—epilepsy syndrome	5.95e-05	0.000206	CcSEcCtD
Bosentan—Shock—Pregabalin—epilepsy syndrome	5.94e-05	0.000205	CcSEcCtD
Bosentan—Somnolence—Valproic Acid—epilepsy syndrome	5.94e-05	0.000205	CcSEcCtD
Bosentan—Immune system disorder—Topiramate—epilepsy syndrome	5.92e-05	0.000205	CcSEcCtD
Bosentan—Nervous system disorder—Pregabalin—epilepsy syndrome	5.92e-05	0.000205	CcSEcCtD
Bosentan—Cough—Gabapentin—epilepsy syndrome	5.92e-05	0.000205	CcSEcCtD
Bosentan—Thrombocytopenia—Pregabalin—epilepsy syndrome	5.91e-05	0.000204	CcSEcCtD
Bosentan—Mediastinal disorder—Topiramate—epilepsy syndrome	5.91e-05	0.000204	CcSEcCtD
Bosentan—Tachycardia—Pregabalin—epilepsy syndrome	5.9e-05	0.000204	CcSEcCtD
Bosentan—Chills—Topiramate—epilepsy syndrome	5.89e-05	0.000203	CcSEcCtD
Bosentan—Dyspepsia—Valproic Acid—epilepsy syndrome	5.88e-05	0.000203	CcSEcCtD
Bosentan—Skin disorder—Pregabalin—epilepsy syndrome	5.87e-05	0.000203	CcSEcCtD
Bosentan—Hyperhidrosis—Pregabalin—epilepsy syndrome	5.84e-05	0.000202	CcSEcCtD
Bosentan—Vomiting—Clonazepam—epilepsy syndrome	5.83e-05	0.000202	CcSEcCtD
Bosentan—Decreased appetite—Valproic Acid—epilepsy syndrome	5.81e-05	0.000201	CcSEcCtD
Bosentan—Vomiting—Phenytoin—epilepsy syndrome	5.79e-05	0.0002	CcSEcCtD
Bosentan—Rash—Clonazepam—epilepsy syndrome	5.79e-05	0.0002	CcSEcCtD
Bosentan—Dermatitis—Clonazepam—epilepsy syndrome	5.78e-05	0.0002	CcSEcCtD
Bosentan—Chest pain—Gabapentin—epilepsy syndrome	5.78e-05	0.0002	CcSEcCtD
Bosentan—Arthralgia—Gabapentin—epilepsy syndrome	5.78e-05	0.0002	CcSEcCtD
Bosentan—Nausea—Felbamate—epilepsy syndrome	5.78e-05	0.0002	CcSEcCtD
Bosentan—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	5.77e-05	0.000199	CcSEcCtD
Bosentan—Vomiting—Oxcarbazepine—epilepsy syndrome	5.76e-05	0.000199	CcSEcCtD
Bosentan—Fatigue—Valproic Acid—epilepsy syndrome	5.76e-05	0.000199	CcSEcCtD
Bosentan—Anxiety—Gabapentin—epilepsy syndrome	5.76e-05	0.000199	CcSEcCtD
Bosentan—Anorexia—Pregabalin—epilepsy syndrome	5.76e-05	0.000199	CcSEcCtD
Bosentan—Dizziness—Carbamazepine—epilepsy syndrome	5.75e-05	0.000199	CcSEcCtD
Bosentan—Diarrhoea—Lamotrigine—epilepsy syndrome	5.75e-05	0.000199	CcSEcCtD
Bosentan—Headache—Clonazepam—epilepsy syndrome	5.75e-05	0.000199	CcSEcCtD
Bosentan—Rash—Phenytoin—epilepsy syndrome	5.75e-05	0.000199	CcSEcCtD
Bosentan—Mental disorder—Topiramate—epilepsy syndrome	5.75e-05	0.000199	CcSEcCtD
Bosentan—Dermatitis—Phenytoin—epilepsy syndrome	5.74e-05	0.000198	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	5.74e-05	0.000198	CcSEcCtD
Bosentan—Rash—Oxcarbazepine—epilepsy syndrome	5.72e-05	0.000198	CcSEcCtD
Bosentan—Pain—Valproic Acid—epilepsy syndrome	5.71e-05	0.000197	CcSEcCtD
Bosentan—Constipation—Valproic Acid—epilepsy syndrome	5.71e-05	0.000197	CcSEcCtD
Bosentan—Dermatitis—Oxcarbazepine—epilepsy syndrome	5.71e-05	0.000197	CcSEcCtD
Bosentan—Headache—Phenytoin—epilepsy syndrome	5.71e-05	0.000197	CcSEcCtD
Bosentan—Malnutrition—Topiramate—epilepsy syndrome	5.71e-05	0.000197	CcSEcCtD
Bosentan—Erythema—Topiramate—epilepsy syndrome	5.71e-05	0.000197	CcSEcCtD
Bosentan—Discomfort—Gabapentin—epilepsy syndrome	5.71e-05	0.000197	CcSEcCtD
Bosentan—Headache—Oxcarbazepine—epilepsy syndrome	5.68e-05	0.000196	CcSEcCtD
Bosentan—Nausea—Zonisamide—epilepsy syndrome	5.66e-05	0.000195	CcSEcCtD
Bosentan—Dry mouth—Gabapentin—epilepsy syndrome	5.65e-05	0.000195	CcSEcCtD
Bosentan—Hypotension—Pregabalin—epilepsy syndrome	5.64e-05	0.000195	CcSEcCtD
Bosentan—Flatulence—Topiramate—epilepsy syndrome	5.63e-05	0.000194	CcSEcCtD
Bosentan—Dizziness—Lamotrigine—epilepsy syndrome	5.56e-05	0.000192	CcSEcCtD
Bosentan—Anaphylactic shock—Gabapentin—epilepsy syndrome	5.54e-05	0.000191	CcSEcCtD
Bosentan—Oedema—Gabapentin—epilepsy syndrome	5.54e-05	0.000191	CcSEcCtD
Bosentan—Vomiting—Carbamazepine—epilepsy syndrome	5.53e-05	0.000191	CcSEcCtD
Bosentan—Back pain—Topiramate—epilepsy syndrome	5.52e-05	0.000191	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	5.5e-05	0.00019	CcSEcCtD
Bosentan—Infection—Gabapentin—epilepsy syndrome	5.5e-05	0.00019	CcSEcCtD
Bosentan—Muscle spasms—Topiramate—epilepsy syndrome	5.49e-05	0.00019	CcSEcCtD
Bosentan—Rash—Carbamazepine—epilepsy syndrome	5.49e-05	0.00019	CcSEcCtD
Bosentan—Dermatitis—Carbamazepine—epilepsy syndrome	5.48e-05	0.000189	CcSEcCtD
Bosentan—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	5.46e-05	0.000189	CcSEcCtD
Bosentan—Insomnia—Pregabalin—epilepsy syndrome	5.46e-05	0.000189	CcSEcCtD
Bosentan—Nausea—Clonazepam—epilepsy syndrome	5.45e-05	0.000188	CcSEcCtD
Bosentan—Headache—Carbamazepine—epilepsy syndrome	5.45e-05	0.000188	CcSEcCtD
Bosentan—Shock—Gabapentin—epilepsy syndrome	5.45e-05	0.000188	CcSEcCtD
Bosentan—Nervous system disorder—Gabapentin—epilepsy syndrome	5.43e-05	0.000188	CcSEcCtD
Bosentan—Paraesthesia—Pregabalin—epilepsy syndrome	5.42e-05	0.000187	CcSEcCtD
Bosentan—Thrombocytopenia—Gabapentin—epilepsy syndrome	5.42e-05	0.000187	CcSEcCtD
Bosentan—Nausea—Phenytoin—epilepsy syndrome	5.41e-05	0.000187	CcSEcCtD
Bosentan—Tachycardia—Gabapentin—epilepsy syndrome	5.41e-05	0.000187	CcSEcCtD
Bosentan—Dyspnoea—Pregabalin—epilepsy syndrome	5.39e-05	0.000186	CcSEcCtD
Bosentan—Nausea—Oxcarbazepine—epilepsy syndrome	5.39e-05	0.000186	CcSEcCtD
Bosentan—Vision blurred—Topiramate—epilepsy syndrome	5.38e-05	0.000186	CcSEcCtD
Bosentan—Skin disorder—Gabapentin—epilepsy syndrome	5.38e-05	0.000186	CcSEcCtD
Bosentan—Somnolence—Pregabalin—epilepsy syndrome	5.37e-05	0.000186	CcSEcCtD
Bosentan—Hyperhidrosis—Gabapentin—epilepsy syndrome	5.35e-05	0.000185	CcSEcCtD
Bosentan—Tremor—Topiramate—epilepsy syndrome	5.35e-05	0.000185	CcSEcCtD
Bosentan—Vomiting—Lamotrigine—epilepsy syndrome	5.35e-05	0.000185	CcSEcCtD
Bosentan—Urticaria—Valproic Acid—epilepsy syndrome	5.31e-05	0.000183	CcSEcCtD
Bosentan—Rash—Lamotrigine—epilepsy syndrome	5.3e-05	0.000183	CcSEcCtD
Bosentan—Dermatitis—Lamotrigine—epilepsy syndrome	5.3e-05	0.000183	CcSEcCtD
Bosentan—Abdominal pain—Valproic Acid—epilepsy syndrome	5.28e-05	0.000183	CcSEcCtD
Bosentan—Body temperature increased—Valproic Acid—epilepsy syndrome	5.28e-05	0.000183	CcSEcCtD
Bosentan—Anorexia—Gabapentin—epilepsy syndrome	5.28e-05	0.000182	CcSEcCtD
Bosentan—Anaemia—Topiramate—epilepsy syndrome	5.28e-05	0.000182	CcSEcCtD
Bosentan—Headache—Lamotrigine—epilepsy syndrome	5.27e-05	0.000182	CcSEcCtD
Bosentan—Decreased appetite—Pregabalin—epilepsy syndrome	5.25e-05	0.000181	CcSEcCtD
Bosentan—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	5.21e-05	0.00018	CcSEcCtD
Bosentan—Fatigue—Pregabalin—epilepsy syndrome	5.21e-05	0.00018	CcSEcCtD
Bosentan—Hypotension—Gabapentin—epilepsy syndrome	5.18e-05	0.000179	CcSEcCtD
Bosentan—Nausea—Carbamazepine—epilepsy syndrome	5.17e-05	0.000179	CcSEcCtD
Bosentan—Constipation—Pregabalin—epilepsy syndrome	5.17e-05	0.000179	CcSEcCtD
Bosentan—Pain—Pregabalin—epilepsy syndrome	5.17e-05	0.000179	CcSEcCtD
Bosentan—Vertigo—Topiramate—epilepsy syndrome	5.13e-05	0.000177	CcSEcCtD
Bosentan—Syncope—Topiramate—epilepsy syndrome	5.12e-05	0.000177	CcSEcCtD
Bosentan—Leukopenia—Topiramate—epilepsy syndrome	5.11e-05	0.000177	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	5.05e-05	0.000174	CcSEcCtD
Bosentan—Palpitations—Topiramate—epilepsy syndrome	5.05e-05	0.000174	CcSEcCtD
Bosentan—Loss of consciousness—Topiramate—epilepsy syndrome	5.02e-05	0.000173	CcSEcCtD
Bosentan—Insomnia—Gabapentin—epilepsy syndrome	5.01e-05	0.000173	CcSEcCtD
Bosentan—Nausea—Lamotrigine—epilepsy syndrome	4.99e-05	0.000173	CcSEcCtD
Bosentan—Cough—Topiramate—epilepsy syndrome	4.98e-05	0.000172	CcSEcCtD
Bosentan—Paraesthesia—Gabapentin—epilepsy syndrome	4.97e-05	0.000172	CcSEcCtD
Bosentan—Gastrointestinal pain—Pregabalin—epilepsy syndrome	4.94e-05	0.000171	CcSEcCtD
Bosentan—Dyspnoea—Gabapentin—epilepsy syndrome	4.94e-05	0.000171	CcSEcCtD
Bosentan—Somnolence—Gabapentin—epilepsy syndrome	4.92e-05	0.00017	CcSEcCtD
Bosentan—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.92e-05	0.00017	CcSEcCtD
Bosentan—Dyspepsia—Gabapentin—epilepsy syndrome	4.88e-05	0.000169	CcSEcCtD
Bosentan—Arthralgia—Topiramate—epilepsy syndrome	4.86e-05	0.000168	CcSEcCtD
Bosentan—Chest pain—Topiramate—epilepsy syndrome	4.86e-05	0.000168	CcSEcCtD
Bosentan—Anxiety—Topiramate—epilepsy syndrome	4.84e-05	0.000167	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	4.83e-05	0.000167	CcSEcCtD
Bosentan—Decreased appetite—Gabapentin—epilepsy syndrome	4.81e-05	0.000166	CcSEcCtD
Bosentan—Discomfort—Topiramate—epilepsy syndrome	4.8e-05	0.000166	CcSEcCtD
Bosentan—Urticaria—Pregabalin—epilepsy syndrome	4.8e-05	0.000166	CcSEcCtD
Bosentan—Asthenia—Valproic Acid—epilepsy syndrome	4.79e-05	0.000166	CcSEcCtD
Bosentan—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	4.78e-05	0.000165	CcSEcCtD
Bosentan—Fatigue—Gabapentin—epilepsy syndrome	4.78e-05	0.000165	CcSEcCtD
Bosentan—Abdominal pain—Pregabalin—epilepsy syndrome	4.78e-05	0.000165	CcSEcCtD
Bosentan—Body temperature increased—Pregabalin—epilepsy syndrome	4.78e-05	0.000165	CcSEcCtD
Bosentan—Dry mouth—Topiramate—epilepsy syndrome	4.75e-05	0.000164	CcSEcCtD
Bosentan—Pain—Gabapentin—epilepsy syndrome	4.74e-05	0.000164	CcSEcCtD
Bosentan—Constipation—Gabapentin—epilepsy syndrome	4.74e-05	0.000164	CcSEcCtD
Bosentan—Pruritus—Valproic Acid—epilepsy syndrome	4.73e-05	0.000163	CcSEcCtD
Bosentan—Oedema—Topiramate—epilepsy syndrome	4.66e-05	0.000161	CcSEcCtD
Bosentan—Infection—Topiramate—epilepsy syndrome	4.63e-05	0.00016	CcSEcCtD
Bosentan—Shock—Topiramate—epilepsy syndrome	4.58e-05	0.000158	CcSEcCtD
Bosentan—Diarrhoea—Valproic Acid—epilepsy syndrome	4.57e-05	0.000158	CcSEcCtD
Bosentan—Nervous system disorder—Topiramate—epilepsy syndrome	4.57e-05	0.000158	CcSEcCtD
Bosentan—Thrombocytopenia—Topiramate—epilepsy syndrome	4.56e-05	0.000158	CcSEcCtD
Bosentan—Tachycardia—Topiramate—epilepsy syndrome	4.55e-05	0.000157	CcSEcCtD
Bosentan—Gastrointestinal pain—Gabapentin—epilepsy syndrome	4.53e-05	0.000157	CcSEcCtD
Bosentan—Skin disorder—Topiramate—epilepsy syndrome	4.53e-05	0.000156	CcSEcCtD
Bosentan—Hyperhidrosis—Topiramate—epilepsy syndrome	4.5e-05	0.000156	CcSEcCtD
Bosentan—Hypersensitivity—Pregabalin—epilepsy syndrome	4.45e-05	0.000154	CcSEcCtD
Bosentan—Anorexia—Topiramate—epilepsy syndrome	4.44e-05	0.000154	CcSEcCtD
Bosentan—Dizziness—Valproic Acid—epilepsy syndrome	4.42e-05	0.000153	CcSEcCtD
Bosentan—Urticaria—Gabapentin—epilepsy syndrome	4.4e-05	0.000152	CcSEcCtD
Bosentan—Body temperature increased—Gabapentin—epilepsy syndrome	4.38e-05	0.000151	CcSEcCtD
Bosentan—Abdominal pain—Gabapentin—epilepsy syndrome	4.38e-05	0.000151	CcSEcCtD
Bosentan—Hypotension—Topiramate—epilepsy syndrome	4.35e-05	0.00015	CcSEcCtD
Bosentan—Asthenia—Pregabalin—epilepsy syndrome	4.33e-05	0.00015	CcSEcCtD
Bosentan—Pruritus—Pregabalin—epilepsy syndrome	4.27e-05	0.000148	CcSEcCtD
Bosentan—Vomiting—Valproic Acid—epilepsy syndrome	4.25e-05	0.000147	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	4.25e-05	0.000147	CcSEcCtD
Bosentan—Insomnia—Topiramate—epilepsy syndrome	4.21e-05	0.000146	CcSEcCtD
Bosentan—Rash—Valproic Acid—epilepsy syndrome	4.21e-05	0.000146	CcSEcCtD
Bosentan—Dermatitis—Valproic Acid—epilepsy syndrome	4.21e-05	0.000145	CcSEcCtD
Bosentan—Headache—Valproic Acid—epilepsy syndrome	4.19e-05	0.000145	CcSEcCtD
Bosentan—Paraesthesia—Topiramate—epilepsy syndrome	4.18e-05	0.000145	CcSEcCtD
Bosentan—Dyspnoea—Topiramate—epilepsy syndrome	4.15e-05	0.000144	CcSEcCtD
Bosentan—Somnolence—Topiramate—epilepsy syndrome	4.14e-05	0.000143	CcSEcCtD
Bosentan—Diarrhoea—Pregabalin—epilepsy syndrome	4.13e-05	0.000143	CcSEcCtD
Bosentan—Dyspepsia—Topiramate—epilepsy syndrome	4.1e-05	0.000142	CcSEcCtD
Bosentan—Hypersensitivity—Gabapentin—epilepsy syndrome	4.08e-05	0.000141	CcSEcCtD
Bosentan—Decreased appetite—Topiramate—epilepsy syndrome	4.05e-05	0.00014	CcSEcCtD
Bosentan—Gastrointestinal disorder—Topiramate—epilepsy syndrome	4.02e-05	0.000139	CcSEcCtD
Bosentan—Fatigue—Topiramate—epilepsy syndrome	4.02e-05	0.000139	CcSEcCtD
Bosentan—Dizziness—Pregabalin—epilepsy syndrome	3.99e-05	0.000138	CcSEcCtD
Bosentan—Constipation—Topiramate—epilepsy syndrome	3.98e-05	0.000138	CcSEcCtD
Bosentan—Pain—Topiramate—epilepsy syndrome	3.98e-05	0.000138	CcSEcCtD
Bosentan—Asthenia—Gabapentin—epilepsy syndrome	3.97e-05	0.000137	CcSEcCtD
Bosentan—Nausea—Valproic Acid—epilepsy syndrome	3.97e-05	0.000137	CcSEcCtD
Bosentan—Pruritus—Gabapentin—epilepsy syndrome	3.92e-05	0.000135	CcSEcCtD
Bosentan—Vomiting—Pregabalin—epilepsy syndrome	3.84e-05	0.000133	CcSEcCtD
Bosentan—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.81e-05	0.000132	CcSEcCtD
Bosentan—Rash—Pregabalin—epilepsy syndrome	3.81e-05	0.000132	CcSEcCtD
Bosentan—Dermatitis—Pregabalin—epilepsy syndrome	3.81e-05	0.000132	CcSEcCtD
Bosentan—Diarrhoea—Gabapentin—epilepsy syndrome	3.79e-05	0.000131	CcSEcCtD
Bosentan—Headache—Pregabalin—epilepsy syndrome	3.78e-05	0.000131	CcSEcCtD
Bosentan—Urticaria—Topiramate—epilepsy syndrome	3.7e-05	0.000128	CcSEcCtD
Bosentan—Body temperature increased—Topiramate—epilepsy syndrome	3.68e-05	0.000127	CcSEcCtD
Bosentan—Abdominal pain—Topiramate—epilepsy syndrome	3.68e-05	0.000127	CcSEcCtD
Bosentan—Dizziness—Gabapentin—epilepsy syndrome	3.66e-05	0.000127	CcSEcCtD
Bosentan—Nausea—Pregabalin—epilepsy syndrome	3.59e-05	0.000124	CcSEcCtD
Bosentan—Vomiting—Gabapentin—epilepsy syndrome	3.52e-05	0.000122	CcSEcCtD
Bosentan—Rash—Gabapentin—epilepsy syndrome	3.49e-05	0.000121	CcSEcCtD
Bosentan—Dermatitis—Gabapentin—epilepsy syndrome	3.49e-05	0.000121	CcSEcCtD
Bosentan—Headache—Gabapentin—epilepsy syndrome	3.47e-05	0.00012	CcSEcCtD
Bosentan—Hypersensitivity—Topiramate—epilepsy syndrome	3.43e-05	0.000119	CcSEcCtD
Bosentan—Asthenia—Topiramate—epilepsy syndrome	3.34e-05	0.000116	CcSEcCtD
Bosentan—Pruritus—Topiramate—epilepsy syndrome	3.3e-05	0.000114	CcSEcCtD
Bosentan—Nausea—Gabapentin—epilepsy syndrome	3.29e-05	0.000114	CcSEcCtD
Bosentan—Diarrhoea—Topiramate—epilepsy syndrome	3.19e-05	0.00011	CcSEcCtD
Bosentan—Dizziness—Topiramate—epilepsy syndrome	3.08e-05	0.000106	CcSEcCtD
Bosentan—Vomiting—Topiramate—epilepsy syndrome	2.96e-05	0.000102	CcSEcCtD
Bosentan—Rash—Topiramate—epilepsy syndrome	2.94e-05	0.000102	CcSEcCtD
Bosentan—Dermatitis—Topiramate—epilepsy syndrome	2.94e-05	0.000101	CcSEcCtD
Bosentan—Headache—Topiramate—epilepsy syndrome	2.92e-05	0.000101	CcSEcCtD
Bosentan—Nausea—Topiramate—epilepsy syndrome	2.77e-05	9.57e-05	CcSEcCtD
Bosentan—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	2.67e-05	0.00018	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—KCNJ11—epilepsy syndrome	2.66e-05	0.00018	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CHRM3—epilepsy syndrome	2.66e-05	0.00018	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—S100B—epilepsy syndrome	2.65e-05	0.000179	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—HSPB1—epilepsy syndrome	2.65e-05	0.000179	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—OXT—epilepsy syndrome	2.65e-05	0.000179	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CXCL2—epilepsy syndrome	2.65e-05	0.000179	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CRH—epilepsy syndrome	2.65e-05	0.000179	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCL3—epilepsy syndrome	2.65e-05	0.000179	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—SOCS3—epilepsy syndrome	2.63e-05	0.000177	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CDC42—epilepsy syndrome	2.62e-05	0.000177	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CCR5—epilepsy syndrome	2.61e-05	0.000177	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—HTR2A—epilepsy syndrome	2.56e-05	0.000173	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—AVP—epilepsy syndrome	2.54e-05	0.000171	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.48e-05	0.000168	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.47e-05	0.000167	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TSC1—epilepsy syndrome	2.46e-05	0.000166	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PTK2B—epilepsy syndrome	2.46e-05	0.000166	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	2.44e-05	0.000165	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.43e-05	0.000164	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—AGT—epilepsy syndrome	2.43e-05	0.000164	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	2.41e-05	0.000163	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—HES1—epilepsy syndrome	2.4e-05	0.000162	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SST—epilepsy syndrome	2.4e-05	0.000162	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NTRK2—epilepsy syndrome	2.4e-05	0.000162	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCR2—epilepsy syndrome	2.4e-05	0.000162	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—DUSP6—epilepsy syndrome	2.37e-05	0.00016	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ADRA2A—epilepsy syndrome	2.34e-05	0.000158	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PLAT—epilepsy syndrome	2.33e-05	0.000158	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—FYN—epilepsy syndrome	2.33e-05	0.000158	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—H2AFX—epilepsy syndrome	2.32e-05	0.000157	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MEF2C—epilepsy syndrome	2.32e-05	0.000157	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	2.27e-05	0.000154	CbGpPWpGaD
Bosentan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	2.25e-05	0.000152	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—BDKRB2—epilepsy syndrome	2.25e-05	0.000152	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CXCL12—epilepsy syndrome	2.25e-05	0.000152	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—POMC—epilepsy syndrome	2.25e-05	0.000152	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—YWHAZ—epilepsy syndrome	2.24e-05	0.000152	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—PRKCB—epilepsy syndrome	2.24e-05	0.000151	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL6ST—epilepsy syndrome	2.23e-05	0.000151	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—NGF—epilepsy syndrome	2.22e-05	0.00015	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CNR1—epilepsy syndrome	2.21e-05	0.000149	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—JUNB—epilepsy syndrome	2.21e-05	0.000149	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PLCB1—epilepsy syndrome	2.2e-05	0.000149	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ABCG2—epilepsy syndrome	2.17e-05	0.000147	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CCR5—epilepsy syndrome	2.16e-05	0.000146	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—HTR7—epilepsy syndrome	2.16e-05	0.000146	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PDXK—epilepsy syndrome	2.14e-05	0.000145	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—FAR1—epilepsy syndrome	2.14e-05	0.000145	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GLUD1—epilepsy syndrome	2.14e-05	0.000145	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—L2HGDH—epilepsy syndrome	2.14e-05	0.000145	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CERS1—epilepsy syndrome	2.14e-05	0.000145	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ADK—epilepsy syndrome	2.14e-05	0.000145	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CYP2C19—epilepsy syndrome	2.12e-05	0.000143	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—HTR2A—epilepsy syndrome	2.11e-05	0.000143	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CYP11A1—epilepsy syndrome	2.1e-05	0.000142	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—HBEGF—epilepsy syndrome	2.09e-05	0.000141	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.09e-05	0.000141	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—AKT3—epilepsy syndrome	2.06e-05	0.000139	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—POMC—epilepsy syndrome	2.04e-05	0.000138	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ADAM10—epilepsy syndrome	2.01e-05	0.000136	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TSC2—epilepsy syndrome	2.01e-05	0.000135	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—AGT—epilepsy syndrome	2e-05	0.000135	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CCL2—epilepsy syndrome	2e-05	0.000135	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—APOE—epilepsy syndrome	1.96e-05	0.000133	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—EPM2A—epilepsy syndrome	1.96e-05	0.000132	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NHLRC1—epilepsy syndrome	1.96e-05	0.000132	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GAMT—epilepsy syndrome	1.96e-05	0.000132	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PNPO—epilepsy syndrome	1.96e-05	0.000132	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—KDR—epilepsy syndrome	1.92e-05	0.00013	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.9e-05	0.000129	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—S100B—epilepsy syndrome	1.9e-05	0.000128	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CYP2D6—epilepsy syndrome	1.9e-05	0.000128	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SOCS3—epilepsy syndrome	1.88e-05	0.000127	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CDC42—epilepsy syndrome	1.88e-05	0.000127	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.86e-05	0.000126	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PRKCB—epilepsy syndrome	1.85e-05	0.000125	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL6ST—epilepsy syndrome	1.84e-05	0.000125	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CA4—epilepsy syndrome	1.82e-05	0.000123	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—QDPR—epilepsy syndrome	1.82e-05	0.000123	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—AVP—epilepsy syndrome	1.82e-05	0.000123	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—POMC—epilepsy syndrome	1.82e-05	0.000123	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ADRA2A—epilepsy syndrome	1.81e-05	0.000122	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—BCHE—epilepsy syndrome	1.8e-05	0.000122	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—HES1—epilepsy syndrome	1.72e-05	0.000116	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—SLC2A1—epilepsy syndrome	1.72e-05	0.000116	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—COX3—epilepsy syndrome	1.71e-05	0.000116	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PLCB1—epilepsy syndrome	1.7e-05	0.000115	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—TH—epilepsy syndrome	1.69e-05	0.000114	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—POMC—epilepsy syndrome	1.69e-05	0.000114	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—FYN—epilepsy syndrome	1.67e-05	0.000113	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.67e-05	0.000113	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—H2AFX—epilepsy syndrome	1.66e-05	0.000112	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MEF2C—epilepsy syndrome	1.66e-05	0.000112	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CCL2—epilepsy syndrome	1.65e-05	0.000111	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	1.62e-05	0.00011	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PFKL—epilepsy syndrome	1.62e-05	0.00011	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	1.62e-05	0.00011	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	1.62e-05	0.00011	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	1.62e-05	0.00011	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—YWHAZ—epilepsy syndrome	1.61e-05	0.000108	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NGF—epilepsy syndrome	1.59e-05	0.000107	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.59e-05	0.000107	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.58e-05	0.000107	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCR5—epilepsy syndrome	1.54e-05	0.000104	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—HTR2A—epilepsy syndrome	1.51e-05	0.000102	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—FGF2—epilepsy syndrome	1.49e-05	0.000101	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—UPB1—epilepsy syndrome	1.48e-05	0.0001	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ATIC—epilepsy syndrome	1.48e-05	0.0001	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NEU1—epilepsy syndrome	1.48e-05	0.0001	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TSC2—epilepsy syndrome	1.44e-05	9.7e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—AGT—epilepsy syndrome	1.43e-05	9.68e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	1.43e-05	9.65e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.41e-05	9.54e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.41e-05	9.54e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.41e-05	9.54e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.41e-05	9.54e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.41e-05	9.54e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.41e-05	9.54e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—HMOX1—epilepsy syndrome	1.41e-05	9.54e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—APOE—epilepsy syndrome	1.4e-05	9.49e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CAT—epilepsy syndrome	1.39e-05	9.41e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—RELA—epilepsy syndrome	1.38e-05	9.35e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GBE1—epilepsy syndrome	1.38e-05	9.32e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	1.38e-05	9.32e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—KDR—epilepsy syndrome	1.38e-05	9.3e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MTOR—epilepsy syndrome	1.36e-05	9.17e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ABCB1—epilepsy syndrome	1.36e-05	9.16e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.35e-05	9.11e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PRKCB—epilepsy syndrome	1.32e-05	8.95e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL6ST—epilepsy syndrome	1.32e-05	8.91e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	1.3e-05	8.77e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.29e-05	8.73e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.29e-05	8.73e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.29e-05	8.73e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.29e-05	8.73e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	1.26e-05	8.53e-05	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—AKT1—epilepsy syndrome	1.26e-05	8.51e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GPX1—epilepsy syndrome	1.26e-05	8.51e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CASP3—epilepsy syndrome	1.25e-05	8.43e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NT5E—epilepsy syndrome	1.23e-05	8.31e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALAD—epilepsy syndrome	1.23e-05	8.31e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—JUN—epilepsy syndrome	1.21e-05	8.19e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—POMC—epilepsy syndrome	1.21e-05	8.15e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.2e-05	8.11e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.2e-05	8.11e-05	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.2e-05	8.09e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCL2—epilepsy syndrome	1.18e-05	7.98e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MMP9—epilepsy syndrome	1.18e-05	7.97e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	1.17e-05	7.93e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	1.17e-05	7.93e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	1.15e-05	7.76e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—AKT1—epilepsy syndrome	1.14e-05	7.73e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.13e-05	7.63e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ADSL—epilepsy syndrome	1.13e-05	7.6e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—AGT—epilepsy syndrome	1.1e-05	7.46e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GLUL—epilepsy syndrome	1.1e-05	7.45e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—SRC—epilepsy syndrome	1.09e-05	7.35e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	1.08e-05	7.32e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—APOE—epilepsy syndrome	1.08e-05	7.31e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.07e-05	7.23e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.07e-05	7.23e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.07e-05	7.23e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.07e-05	7.23e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.07e-05	7.23e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—FGF2—epilepsy syndrome	1.07e-05	7.21e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—VEGFA—epilepsy syndrome	1.06e-05	7.16e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	1.01e-05	6.84e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—RELA—epilepsy syndrome	9.9e-06	6.69e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—AQP1—epilepsy syndrome	9.83e-06	6.64e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—UPB1—epilepsy syndrome	9.79e-06	6.61e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NEU1—epilepsy syndrome	9.79e-06	6.61e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ATIC—epilepsy syndrome	9.79e-06	6.61e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MTOR—epilepsy syndrome	9.71e-06	6.56e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	9.45e-06	6.38e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	9.42e-06	6.37e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—POMC—epilepsy syndrome	9.3e-06	6.28e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	9.1e-06	6.15e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GBE1—epilepsy syndrome	9.1e-06	6.15e-05	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—AKT1—epilepsy syndrome	9.02e-06	6.09e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CASP3—epilepsy syndrome	8.93e-06	6.04e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	8.89e-06	6.01e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	8.89e-06	6.01e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—JUN—epilepsy syndrome	8.68e-06	5.86e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	8.56e-06	5.78e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ALB—epilepsy syndrome	8.48e-06	5.73e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MMP9—epilepsy syndrome	8.44e-06	5.7e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	8.32e-06	5.62e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	8.28e-06	5.6e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—AKT1—epilepsy syndrome	8.19e-06	5.53e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	8.12e-06	5.48e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NT5E—epilepsy syndrome	8.11e-06	5.48e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALAD—epilepsy syndrome	8.11e-06	5.48e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SRC—epilepsy syndrome	7.78e-06	5.26e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	7.74e-06	5.23e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	7.74e-06	5.23e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—VEGFA—epilepsy syndrome	7.58e-06	5.12e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	7.57e-06	5.12e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ADSL—epilepsy syndrome	7.42e-06	5.01e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PTGS2—epilepsy syndrome	7.42e-06	5.01e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GLUL—epilepsy syndrome	7.28e-06	4.92e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	7.25e-06	4.9e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	7.14e-06	4.83e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	7.07e-06	4.77e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	7.02e-06	4.74e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	6.97e-06	4.71e-05	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—AKT1—epilepsy syndrome	6.76e-06	4.57e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	6.68e-06	4.51e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—AQP1—epilepsy syndrome	6.49e-06	4.38e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	6.36e-06	4.29e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	6.34e-06	4.28e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	6.03e-06	4.08e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—BCHE—epilepsy syndrome	6.01e-06	4.06e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	5.87e-06	3.96e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	5.87e-06	3.96e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	5.73e-06	3.87e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	5.67e-06	3.83e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—TH—epilepsy syndrome	5.65e-06	3.82e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	5.56e-06	3.76e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—AKT1—epilepsy syndrome	4.84e-06	3.27e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	4.78e-06	3.23e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	4.71e-06	3.18e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	4.66e-06	3.15e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CAT—epilepsy syndrome	4.65e-06	3.14e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	4.63e-06	3.13e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	4.52e-06	3.06e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GPX1—epilepsy syndrome	4.21e-06	2.84e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	4.18e-06	2.82e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	3.98e-06	2.69e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—BCHE—epilepsy syndrome	3.96e-06	2.68e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	3.78e-06	2.55e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	3.74e-06	2.53e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—AKT1—epilepsy syndrome	3.73e-06	2.52e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—TH—epilepsy syndrome	3.73e-06	2.52e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—AGT—epilepsy syndrome	3.69e-06	2.49e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—APOE—epilepsy syndrome	3.61e-06	2.44e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	3.11e-06	2.1e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—POMC—epilepsy syndrome	3.1e-06	2.1e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CAT—epilepsy syndrome	3.07e-06	2.07e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.98e-06	2.02e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALB—epilepsy syndrome	2.83e-06	1.91e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.77e-06	1.87e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	2.48e-06	1.67e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.43e-06	1.64e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—APOE—epilepsy syndrome	2.38e-06	1.61e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—POMC—epilepsy syndrome	2.05e-06	1.38e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.87e-06	1.26e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.63e-06	1.1e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—AKT1—epilepsy syndrome	1.24e-06	8.41e-06	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—AKT1—epilepsy syndrome	8.21e-07	5.55e-06	CbGpPWpGaD
